IP Library Assignment 035695/0204
Patent Assignment
Reel/Frame 035695/0204

Merger

Recorded: 2015-05-22 Pages: 4
Assignor
MEDAREX, L.L.C.
Executed: 2014-09-30
Assignee
E. R. SQUIBB & SONS, L.L.C.
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NEW JERSEY, 08540
Covered Property (1)
Methods of Treating Conditions Caused by Increased Expression of Nerve Growth Factor (Ngf) or Increased Sensitivity to Ngf Using Anti-Ngf Neutralizing Antibodies as Selective Ngf Pathway Inhibitors
Patent: 9,260,514 →
Application: 12/576,522 →
Publication: US 2010/0034818
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger Aug 15, 2013
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 031016/0678 →